Local Institution

Concord, California 94520

0 studies enrolling now · 6 studies all time

What they study most

Bladder Cancer, Diabetes Mellitus, Diabetes Mellitus II, Diabetes, Type 2, Metastasis, Non-Small-Cell Lung Carcinoma, Transitional Cell Carcinoma, Type 2 Diabetes Mellitus

Studies at this site

• Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer — Completed
• First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy — Completed
• PPAR - Combination With Metformin — Completed
• A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control — Completed
• Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes — Completed
• Dose Ranging Study With LT, Monotherapy, PPAR — Completed